One pathology lab is acquired; another changes name

Article

Urology service provider HealthTronics Inc. has purchased UroPath LLC, an anatomic pathology laboratory services provider, for $7.5 million.

Urology service provider HealthTronics Inc. has purchased UroPath LLC, an anatomic pathology laboratory services provider, for $7.5 million.

In 2007, labs managed by UroPath processed more than 400,000 specimens for more than 50 urology practices with more than 450 physicians over 17 states. UroPath's operating model has focused on the patient benefits of a disease-focused diagnosis capability for prostate health with greater involvement by the urologist, who often acts as the primary care physician when dealing with prostate disease, HealthTronics said in a statement.

“We believe UroPath’s historical model provides greater continuity in the handling of specimens, increased communication between specialists in the continuum of care, and improved focus on the needs of the patient,” said HealthTronics CEO James S.B. Whittenburg.

In related news, Lakewood Pathology Associates has changes its name to PLUS Diagnostics to more accurately represent its role as a national provider of anatomic pathology and diagnostic services. PLUS stands for Pathology Laboratory of the United States.

“Our new name, particularly the word, PLUS, embodies our company’s commitment to provide our customers with innovative and specialized services,” Doug Berg, Lakewood Pathology Associates’ CEO, said.

Lakewood will officially become PLUS Diagnostics on Aug. 4.

Related Videos
Dr. Mehmet Asim Bilen in an interview with Urology Times
Anne M. Suskind, MD, MS, FACS, FPMRS, answers a question during a Zoom video interview
blurred clinic hallway
Female doctor using laptop | Image Credit: © nenetus - stock.adobe.com
Kathryn Marchetti, MD, answers a question during a Zoom video interview
Dr. Mayer Fishman in an interview with Urology Times
Man talking with doctor | Image Credit: © Khunatorn - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.